Who has invested in Kynexis?

Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures are named among the investors backing Kynexis.

Kynexis Funding: $61M Raised, Series A (2023)

Kynexis funding overview

Kynexis is based in Cambridge, MA. Kynexis has raised $61M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2023. The round record for Kynexis runs through 2023; nothing later has been disclosed. Investors on record include Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures. 3 distinct backers are named across the disclosed rounds.

Kynexis at a glance

Total raised: $61M
Latest round: Series A
Latest round date: November 2023
Headquarters: Cambridge, MA
Notable investors: Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures

Frequently asked about Kynexis funding

How much has Kynexis raised?: Kynexis has raised $61M in total disclosed funding across the rounds on record.
Who has invested in Kynexis?: Forbion Capital Partners, Ysios Capital, Sunstone Life Science Ventures are named among the investors backing Kynexis.
What was the latest Kynexis funding round?: The most recent disclosed round is a Series A, announced in November 2023.
Where is Kynexis based?: Kynexis is based in Cambridge, MA.
When did Kynexis last raise?: The last disclosed Kynexis round closed in November 2023 at Series A.

Kynexis totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.

Kynexis Funding: $61M Raised, Series A (2023)

Kynexis funding overview

Kynexis at a glance

Frequently asked about Kynexis funding

Companies related to Kynexis (21)

Browse related funding lists (5)